awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41595492-043CEF4C-2A8C-475C-ABE1-3AD40BFAF42B
Q41595492-043CEF4C-2A8C-475C-ABE1-3AD40BFAF42B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41595492-043CEF4C-2A8C-475C-ABE1-3AD40BFAF42B
Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors.
P2860
Q41595492-043CEF4C-2A8C-475C-ABE1-3AD40BFAF42B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41595492-043CEF4C-2A8C-475C-ABE1-3AD40BFAF42B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e95aba492c2daa292834fa4748b6350ebe777ca4
P2860
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.